Tang et al. [43] further demonstrated that ATL I reduces cancer cell stemness and invasiveness by decreasing the activity of colorectal cancer stem cells and restricting the transfer of carcinogenic miR-200c via extracellular vesicle uptake, thereby inhibiting the PI3K/Akt/mTOR signaling pathway. Here, MTOR is linked to colorectal cancer.